Modulation of opioid analgesia by agmatine

European Journal of Pharmacology

Volumn 296, Issue 1, 1996, Pages 17-22

  Kolesnikov, Yuri ^a   Jain, Subash ^a   Pasternak, Gavril W ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Agmatine; Analgesia; Morphine; Tolerance

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; AGMATINE; DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; IDAZOXAN; KAPPA 1 OPIATE RECEPTOR AGONIST; KAPPA 3 OPIATE RECEPTOR AGONIST; MORPHINE; NALOXONE BENZOYLHYDRAZONE; OPIATE RECEPTOR; UNCLASSIFIED DRUG; YOHIMBINE;

ANALGESIA; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; GASTROINTESTINAL TRANSIT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

EID: 0030061499     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(95)00669-9     Document Type: Article

References (43)

1. G-nitro-L-arginine methyl ester, Life Sci. 52, 245.
2. Babey, A.-M., Y. Kolesnikov, J. Cheng, C.E. Inturrisi, R.R. Trifilletti and G.W. Pasternak, 1994, Nitric oxide and opioid tolerance, Neuropharmacology 33, 1463.
3. Ben-Eliyahu, S., P. Marek, A.L. Vaccarino, J.S. Mogil, W.F. Sternberg and J.C. Liebeskind, 1992, The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res, 575, 304.
4. Bhargava, H.N., 1994, Nitric oxide synthase inhibition blocks tolerance to the analgesic action of kappa-opiate receptor agonist in the rat, Pharmacology 48, 234.
5. Bhargava, H.N., 1995, Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50,488H, a kappa-opiate receptor agonist in the rat, Gen. Pharmacol. 26, 1055.
6. Bhargava, H.N. and S.N. Thorat, 1994, Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa-opioid receptor agonist, in the mouse, Brain Res. 649, 111.
7. Bousquet, P., J. Feldman and J. Schwartz, 1984, Central cardiovascular effects of α-adrenergic drugs: difference between catecholamines and imidazolines, J. Pharmacol. Exp. Ther. 230, 232.
8. Bricca, G., M. Dontenwill, A. Molines, J. Feldman, A. Belcourt and P. Bousquet, 1989, The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem, Eur. J. Pharmacol. 163, 373.
9. 1 system, Eur. J. Pharmacol. 250, R7.
10. Coupry, I., R.A. Podevin, J.-P. Dausse and A. Parini, 1987, Evidence for imiazoline binding sites in basolateral membranes from rabbit kidney, Biochem. Biophys. Res. Commun. 147, 1055.
11. Coupry, I., D. Atlas, R.-A. Podevin, I. Uzielli and A. Parini, 1990, Imidazoline-guanidinium receptive site in renal proximal tubule: asymmetric distribution, regulation by cations and interaction with an endogenous clonidine displacing substance, J. Pharmacol. Exp. Ther. 252, 293.
12. G-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids, Pain 56, 69.
13. 2-adrenoreceptors in the ventrolateral medulla, Eur. J. Pharmacol. 134, 1.
14. Ernsberger, P., M.P. Meeley and D.J. Reis, 1988, An endogenous substance with clonidine-like properties: selective binding to imidazole sites in the ventrolateral medulla, Brain Res. 441, 309.
15. Ernsberger, P., G. Feinland, M.P. Meeley and D.J. Reis, 1990a, Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substance, Am. J. Hypertens. 3, 90.
16. Ernsberger, P., R. Giuliano, R.N. Willette, R.R. Granata and D.J. Reis, 1990b, Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla, J. Pharmacol. Exp. Ther. 253, 408.
17. Gutstein, H.B. and K.A. Trujillo, 1993, MK-801 inhibits the development of morphine tolerance at spinal sites, Brain Res. 626, 332.
18. Iglesias, V., L.F. Alguacil, C. Alamo and E. Cuenca, 1992, Effects of yohimbine on morphine analgesia and physical dependence in the rat, Eur. J. Pharmacol. 211, 35.
19. Inturrisi, C.E., 1994, NMDA receptors, nitric oxide and opioid tolerance, Regul. Pept. 54, 129.
20. G-Nitro-L-arginine prevents morphine tolerance, Eur. J. Pharmacol. 221, 339.
21. Kolesnikov, Y.A., C.G. Pick, G. Ciszewska and G.W. Pasternak, 1993a, Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor, Proc. Natl. Acad. Sci. USA 90, 5162.
22. 1 opioid analgesic tolerance by NPC17742, a novel NMDA antagonist, Life Sci. 53, 1489.
23. Kolesnikov, Y.A., M.-L. Maccechini and G.W. Pasternak, 1994, 1-Aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance. Life Sci. 55, 1393.
24. Li, G., S. Regunathan, C.J. Barrow, J. Eshraghi, R. Cooper and D.J. Reis, 1994, Agmatine: an endogenous clonidine-displacing substance in the brain, Science 263, 966.
25. London, E.D., D.B. Vaupel and A.S. Kimes, 1994, Inhibitors of nitric oxide synthase as potential treatments for opioid withdrawal, Regul. Pept. 54, 165.
26. Luke, M.C., E.F. Hahn, M. Price and G.W. Pasternak, 1988, Irreversible opiate agonists and antagonists: V. Hydrazone and acylhydrazone derivatives of naltrexone. Life Sci. 43, 1249.
27. Michel, M.C. and P. Ernsberger, 1992, Keeping an eye on the I-site: imidazoline-preferring receptors, Trends Pharmacol. Sci. 13, 369.
28. Michel, M.C. and P.A. Insel, 1989, How many imidazoline-preferring binding sites are there?, Trends Pharmacol. Sci. 10, 342.
29. 2-adrenergic receptors, Mol. Pharmacol. 37, 65.
30. Paul, D. and G.W. Pasternak, 1988, Differential blockade by naloxonazine of two μ opiate actions: analgesia and inhibition of gastrointestinal transit, Eur. J. Pharmacol. 149, 403.
31. Paul, D., J.A. Levison, D.H. Howard, C.G. Pick, E.F. Hahn and G.W. Pasternak, 1990, Naloxone benzoylhydrazone (NalBzoH) analgesia, J. Pharmacol. Exp. Ther. 255, 769.
32. Raasch, W., S. Regunathan, G. Li and D.J. Reis, 1995, Agmatine, the bacterial amine, is widely distributed in mammalian tissues, Life Sci. 56, 2319.
33. Regunathan, S., D.L. Feinstein and D.J. Reis, 1993, Expression of non-adrenergic imidazoline sites in rat cerebral cortical astrocytes, J. Neurosci. Res. 34, 681.
34. Regunathan, S., D.L. Feinstein, W. Raasch and D.J. Reis, 1995, Agmatine is localized and synthesized in glial cells, NeuroReport (in press).
35. Reis, D.J., G. Li and S. Regunathan, 1995, Endogenous ligands of imidazoline receptors: classic and immunoreactive clonidine displacing substance (CDS) and agmatine, Ann. NY Acad. Sci. (in press).
36. Rossi, G.C., G.W, Pasternak and R.J. Bodnar, 1994, μ and δ opioid synergy between the periaqueductal gray and the rostro-ventral medulla, Brain Res. 665, 85.
37. Tabor, C.W. and H. Tabor, 1984, Polyamines, Annu. Rev. Biochem. 53, 749.
38. Thorat, S.N., P.L. Reddy and H.N. Bhargava, 1993, Evidence for the role of nitric oxide in kappa-opiate tolerance in mice, Brain Res. 621, 171.
39. Tiseo, P. and C.E. Inturrisi, 1993, Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate antagonist LY274614, J. Pharmacol. Exp. Ther. 264, 1090.
40. Trujillo, K.A. and H. Akil, 1991, Inhibition of morphine tolerance and dependence by the NMDA receptor anagonist MK-801, Science 251, 85.
41. Trujillo, K.A. and H. Akil, 1994, Inhibition of opiate tolerance by non-competitive N-methyl-D-aspartate receptor antagonists, Brain Res. 633, 178.
42. Umans, J.G. and C.E. Inturrisi, 1981, Pharmacodynamics of subcutaneously administered diacetylmorphine, 6-acetylmorphine and morphine in mice, J. Pharmacol. Exp. Ther. 218, 409.
43. Yaksh, T.L. and R. Noueihed, 1985, The physiology and pharmacology of spinal opiates, Annu. Rev. Pharmacol. Toxicol. 25, 433.